Modulating microtubule stability enhances the cytotoxic response of cancer cells to Paclitaxel.
The extracellular matrix protein TGFBI enhances the cytotoxic response of cancer cells to paclitaxel by affecting integrin signals that stabilize microtubules. Extending the implications of this knowledge, we tested the more general hypothesis that cancer cell signals which increase microtubule stab...
Main Authors: | , , , , , , , , |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2011
|
_version_ | 1797085471731351552 |
---|---|
author | Ahmed, A Wang, X Lu, Z Goldsmith, J Le, X Grandjean, G Bartholomeusz, G Broom, B Bast, R |
author_facet | Ahmed, A Wang, X Lu, Z Goldsmith, J Le, X Grandjean, G Bartholomeusz, G Broom, B Bast, R |
author_sort | Ahmed, A |
collection | OXFORD |
description | The extracellular matrix protein TGFBI enhances the cytotoxic response of cancer cells to paclitaxel by affecting integrin signals that stabilize microtubules. Extending the implications of this knowledge, we tested the more general hypothesis that cancer cell signals which increase microtubule stability before exposure to paclitaxel may increase its ability to stabilize microtubules and thereby enhance its cytotoxicity. Toward this end, we carried out an siRNA screen to evaluate how genetic depletion affected microtubule stabilization, cell viability, and apoptosis. High content microscopic analysis was carried out in the absence or presence of paclitaxel. Kinase knockdowns that stabilized microtubules strongly enhanced the effects of paclitaxel treatment. Conversely, kinase knockdowns that enhanced paclitaxel-mediated cytotoxicity sensitized cells to microtubule stabilization by paclitaxel. The siRNA screen identified several genes that have not been linked previously to microtubule regulation or paclitaxel response. Gene shaving and Bayesian resampling used to classify these genes suggested three pathways of paclitaxel-induced cell death related to apoptosis and microtubule stability, apoptosis alone, or neither process. Our results offer a functional classification of the genetic basis for paclitaxel sensitivity and they support the hypothesis that stabilizing microtubules prior to therapy could enhance antitumor responses to paclitaxel treatment. |
first_indexed | 2024-03-07T02:09:19Z |
format | Journal article |
id | oxford-uuid:a010dee2-a469-46bf-9718-8360d96ae3b1 |
institution | University of Oxford |
language | English |
last_indexed | 2024-03-07T02:09:19Z |
publishDate | 2011 |
record_format | dspace |
spelling | oxford-uuid:a010dee2-a469-46bf-9718-8360d96ae3b12022-03-27T02:02:42ZModulating microtubule stability enhances the cytotoxic response of cancer cells to Paclitaxel.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:a010dee2-a469-46bf-9718-8360d96ae3b1EnglishSymplectic Elements at Oxford2011Ahmed, AWang, XLu, ZGoldsmith, JLe, XGrandjean, GBartholomeusz, GBroom, BBast, RThe extracellular matrix protein TGFBI enhances the cytotoxic response of cancer cells to paclitaxel by affecting integrin signals that stabilize microtubules. Extending the implications of this knowledge, we tested the more general hypothesis that cancer cell signals which increase microtubule stability before exposure to paclitaxel may increase its ability to stabilize microtubules and thereby enhance its cytotoxicity. Toward this end, we carried out an siRNA screen to evaluate how genetic depletion affected microtubule stabilization, cell viability, and apoptosis. High content microscopic analysis was carried out in the absence or presence of paclitaxel. Kinase knockdowns that stabilized microtubules strongly enhanced the effects of paclitaxel treatment. Conversely, kinase knockdowns that enhanced paclitaxel-mediated cytotoxicity sensitized cells to microtubule stabilization by paclitaxel. The siRNA screen identified several genes that have not been linked previously to microtubule regulation or paclitaxel response. Gene shaving and Bayesian resampling used to classify these genes suggested three pathways of paclitaxel-induced cell death related to apoptosis and microtubule stability, apoptosis alone, or neither process. Our results offer a functional classification of the genetic basis for paclitaxel sensitivity and they support the hypothesis that stabilizing microtubules prior to therapy could enhance antitumor responses to paclitaxel treatment. |
spellingShingle | Ahmed, A Wang, X Lu, Z Goldsmith, J Le, X Grandjean, G Bartholomeusz, G Broom, B Bast, R Modulating microtubule stability enhances the cytotoxic response of cancer cells to Paclitaxel. |
title | Modulating microtubule stability enhances the cytotoxic response of cancer cells to Paclitaxel. |
title_full | Modulating microtubule stability enhances the cytotoxic response of cancer cells to Paclitaxel. |
title_fullStr | Modulating microtubule stability enhances the cytotoxic response of cancer cells to Paclitaxel. |
title_full_unstemmed | Modulating microtubule stability enhances the cytotoxic response of cancer cells to Paclitaxel. |
title_short | Modulating microtubule stability enhances the cytotoxic response of cancer cells to Paclitaxel. |
title_sort | modulating microtubule stability enhances the cytotoxic response of cancer cells to paclitaxel |
work_keys_str_mv | AT ahmeda modulatingmicrotubulestabilityenhancesthecytotoxicresponseofcancercellstopaclitaxel AT wangx modulatingmicrotubulestabilityenhancesthecytotoxicresponseofcancercellstopaclitaxel AT luz modulatingmicrotubulestabilityenhancesthecytotoxicresponseofcancercellstopaclitaxel AT goldsmithj modulatingmicrotubulestabilityenhancesthecytotoxicresponseofcancercellstopaclitaxel AT lex modulatingmicrotubulestabilityenhancesthecytotoxicresponseofcancercellstopaclitaxel AT grandjeang modulatingmicrotubulestabilityenhancesthecytotoxicresponseofcancercellstopaclitaxel AT bartholomeuszg modulatingmicrotubulestabilityenhancesthecytotoxicresponseofcancercellstopaclitaxel AT broomb modulatingmicrotubulestabilityenhancesthecytotoxicresponseofcancercellstopaclitaxel AT bastr modulatingmicrotubulestabilityenhancesthecytotoxicresponseofcancercellstopaclitaxel |